A blood sensor hunts Parkinson signals in 40 minutes

A blood sensor hunts Parkinson signals in 40 minutes

21st October 2026

Researchers at KAUST and Oxford built a transistor-based blood sensor that first isolates packages released by nerve cells, then reads three forms of alpha-synuclein - the protein closely tied to Parkinson disease - at very low concentrations in about 40 minutes.

Why it matters - Neurodegeneration erodes healthy years long before it has a name, and Parkinson diagnosis still leans on clinical assessment after movement symptoms appear. A cheap, quick blood read would give doctors and researchers an earlier window - this entry records the first accuracy number and its limits at announcement.

Eight Sleep becomes a medical device - a smart bed for sleep apnea diagnosis in Abu Dhabi

21st October 2026

Eight Sleep announced that its smart bed technology has been approved as a medical device in Abu Dhabi to support at-home diagnosis of obstructive sleep apnea, following a Health Technology Assessment by the Department of Health - Abu Dhabi and announced at the Abu Dhabi Future Health Summit 2026.

Why it matters - Sleep is a core pillar of this library (entry 05). This entry records the moment a leading sleep-tech company moved from wellness tracking into regulated diagnostics - the business pattern preventive health keeps following, from Oura and Function to the bed itself.

Hearing loss tracks mortality - and hearing aids track lower risk

21st October 2026

In an individual participant data meta-analysis of 13,851 people in Australia, Iceland and the US, with replication in 50,277 adults in Norway, hearing loss measured by audiometry was associated with higher all-cause and cardiovascular mortality, rising with severity - mild 1.19, moderate 1.55, and moderately severe or worse 1.56 for all-cause risk. Current hearing aid use was associated with lower risk - 0.91 for all-cause and 0.85 for cardiovascular mortality.

Why it matters - Hearing loss affects more than 1.5 billion people and is routinely left untested and untreated. This is a large, audiometry-based dataset that puts hearing on the same tracking list as blood pressure and ApoB - a number worth knowing, with a plausible intervention already available.

A selfie that predicts survival - facial age as a frailty marker

20th October 2026

Mass General Brigham researchers built FAHR-Face, an AI model trained on more than 40 million facial photographs, and derived two tools from it: FAHR-FaceAge, which estimates the age a person looks, and FAHR-FaceSurvival, which predicts survival directly from a photograph.

Why it matters - This library's clocks so far read blood, DNA and gut microbes. This entry adds the oldest clinical instrument of all - the doctor's eye - now formalised by AI, and records both its first survival numbers and its limits at launch.

Oura learns to count effort - and to guess VO2 max passively

20th October 2026

Oura is rolling out two activity features for Gen3 and newer rings. Cardio Effort scores each workout and a weekly total - Light, Fair, Maintaining, Building or Reaching - from how long heart rate stays elevated relative to the wearer's long-term resting heart rate, shifting the question from minutes moved to whether fitness is being maintained, built or overdone.

Why it matters - The Track pillar runs on a simple rule - measure what predicts, ignore the noise. A ring that estimates cardiorespiratory fitness without a test makes the most predictive number in consumer health ambient; whether the estimate is accurate enough to act on is the open question this entry records at launch.

MTR4 - the RNA guard that keeps blood vessels young

20th October 2026

Researchers publishing in Aging Cell found that MTR4, an RNA helicase, declines in senescent human vascular endothelial cells and in the heart, liver and aorta of aged mice. Silencing MTR4 drove proliferating cells into senescence, while overexpressing it in senescent cells partly reversed the phenotype, because MTR4 stabilises BUB3 and, through it, BUBR1 - a spindle-checkpoint pair that protects DNA during cell division.

Why it matters - Blood vessels age early and drive much of what fails later, from hypertension to frailty. This entry records a conserved, causal anti-senescence factor in the vessel lining at the cell-and-animal stage, so any future therapy claim can be judged against what was actually shown.

Measure, treat, repeat - longevity clinics agree a standard

20th October 2026

At the 4th Roundtable of Longevity Clinics, chaired by Buck Institute CEO Eric Verdin, clinic leaders including Andrea Maier of the NUS Academy for Healthy Longevity argued the sector must move past one-off diagnostic snapshots - the luxury diagnostic trap - to a loop of measure, treat and re-measure. Maier called both extremes unethical: diagnosing without treating, and handing patients whatever test they order without consultation.

Why it matters - Entry 48 recorded academic hospitals entering longevity medicine; this is the clinic sector grading itself. A published standard for what to measure and re-measure would give patients - and this library - a yardstick for separating longevity medicine from wellness retail.

Intrinsic capacity - count what a person can do, not what they have got

20th October 2026

John Beard, who directed the WHO work from which intrinsic capacity emerged and now directs the International Longevity Centre USA at Columbia University, argues that healthy ageing should be measured by function rather than by counting diagnoses.

Why it matters - The previous entry in this library (51) used an intrinsic-capacity clock without pausing on the framework itself. This is the framework's originator grading his own field - a candidate standard for what healthy ageing means, recorded with his warning that enthusiasm is currently outpacing the evidence.

Prenuvo opens its 200,000 scans - the screening dataset becomes a research network

20th October 2026

Prenuvo has launched a Research Network giving more than 50 institutions - City of Hope, UCSF and Moffitt Cancer Center among them - access to its Imaging Biobank of more than 200,000 whole-body MRI scans, which the company describes as the largest dataset of its kind.

Why it matters - Prenuvo is already in this library as the whole-body MRI going mainstream (the V.01 starter set). This is the next business step - the scan archive itself becoming the product for science - and its value depends entirely on the unanswered question the network now has to test: whether spotting abnormalities early in healthy people improves their outcomes.

The gut beats the calendar - microbiome composition predicts inflammation better than age

20th October 2026

In the population-based DanFunD cohort, researchers analysed paired fecal microbiota profiles, 30 plasma cytokines and 19 biochemical and physiological measures in 1,199 adults aged 20-72. Gut microbiota composition explained more variance than chronological age for 97 percent of the cytokines and 84 percent of the physiological variables.

Why it matters - This library tracks inflammaging across several entries (45, 49). This study moves the gut from background influence to a measurable scoreboard - a composition profile that flags inflammatory ageing decades early, in ordinary adults rather than patients.

Cancer, regenerative failure, and the search for longevity biomarkers

20th October 2026

In episode #412, Peter Attia welcomes back oncologist and Pulitzer Prize-winning author Siddhartha Mukherjee, fifteen years after The Emperor of All Maladies, to review what has changed in cancer science: the contributions of genetics, environmental exposures, random mutations and inflammation to risk, the emerging role of hyperinsulinemia and metabolism, and why early detection remains so difficult, particularly in pancreatic cancer.

Why it matters - Cancer is one of the Four Horsemen in this library's founding text (Outlive, in the V.01 starter set). This entry records a leading oncologist connecting his field to the library's core question - whether healthspan is preserved organ by organ, or by defending the repair capacity they all share.

Exercise buffers the ageing clock - especially when sleep is poor or sitting is long

18th October 2026

In the INSPIRE-T cohort in Toulouse, 890 adults aged 20 to 102 each had a measurement of at least one of five biological ageing clocks - PhenoAge, GrimAge, DunedinPACE, iAge and an intrinsic-capacity clock.

Why it matters - Ageing clocks are this library's scoreboard (entries 37 and 46). This is the first entry in the library to show, across five clocks at once, that the score responds to combinations of everyday behaviour - which is how readers actually live, and how future intervention trials should be designed.

Frequent napping as a dementia signal - a marker, not a cause

18th October 2026

In the National Health and Aging Trends Study, researchers followed more than 990 Medicare beneficiaries aged 65 and older who were free of dementia at the start, for up to 10 years from 2013. People who napped most days or every day had a 48 percent higher risk of developing dementia than those who rarely or never napped, unintentional napping was linked to a 39 percent higher risk, and napping for 30 minutes or less to a 40 percent higher risk.

Why it matters - This library already treats sleep as a core longevity lever (entry 05). This study adds the daytime side of that picture: a change in napping pattern is cheap to notice, costs nothing to track, and may be one of the earliest visible signals that brain health deserves a closer look.

Blocking STING helps preserve bone in ageing mice

18th October 2026

Researchers found that the cGAS-STING immune pathway becomes progressively more active in bone marrow macrophages as mice age, driven in part by DPP4 secreted from senescent marrow fat cells together with leaked mitochondrial DNA. Activated STING raised CD38, which degrades NAD+ and its precursor NMN, leaving neighbouring bone-forming stem cells with impaired mitochondria and less capacity to build bone.

Why it matters - Osteoporosis and fracture risk are among the clearest limits on independent living in long lives. This entry records a named, testable mechanism for skeletal ageing - at the mouse stage, so later human claims can be judged against what was actually shown.

Longevity medicine moves into the hospital - academic systems open clinics

18th October 2026

Since last fall, Cedars-Sinai, Northwestern Medicine and Weill Cornell Medicine have launched longevity medicine programs aimed at extending healthspan - the years lived without chronic disease or disability - and Mount Sinai expects to open its program this month.

Why it matters - Longevity medicine is moving from private clinics into academic hospitals. That shift brings research infrastructure and explicit evidence thresholds into a market built on cash-pay testing - and the first visible result is disagreement, in public, about which tests are worth offering at all.

Six longevity myths the experts want retired

17th October 2026

Melinda Wenner Moyer asked leading ageing researchers which popular claims they most want retired, and the answers cut against the online longevity boom - a space where searches quadrupled in a year and feeds fill with supplements and peptide injections.

Why it matters - A calibration piece for the whole library - the researchers themselves restate the rules TLG grades by: healthspan over lifespan, human data over mouse data, and genetics given its due at the extremes of age.

Why big dogs age faster - jumping genes and a methylation clock

17th October 2026

Using 1,640 blood methylomes from 894 companion dogs in the Dog Aging Project, researchers built DNA methylation age predictors accurate to a median error of 0.82 years and found that dogs whose epigenetic age ran ahead of their calendar age faced higher mortality risk.

Why it matters - Dogs share homes, diets and environments with people but age on a compressed clock, which makes them one of the few practical whole-life models for human ageing. This entry records a specific, testable mechanism - loss of control over jumping genes - behind a lifespan difference anyone can observe.

A pill that quiets the inflammasome - MRT-8102 early data

17th October 2026

Monte Rosa reported four-week data for MRT-8102, a once-daily oral molecular glue degrader that removes NEK7, a protein the NLRP3 inflammasome needs to assemble and fire.

Why it matters - Chronic low-grade inflammation is one of the engines this library tracks across entries on inflammaging and immune ageing. A pill that measurably quiets it at the source is worth recording now - at the biomarker stage, so later outcome data can be judged against what was actually shown.

DEAF1 - the switch exercise flips in ageing muscle

17th October 2026

Duke-NUS researchers identified DEAF1, a gene regulator, as a driver of muscle ageing: as FOXO proteins that normally keep it in check fade with age, DEAF1 rises and pushes the mTORC1 growth pathway into chronic overdrive, so muscle cells keep building new proteins while failing to clear damaged ones.

Why it matters - Strength is already this library's core longevity lever (entry 04). This entry gives it a molecular mechanism - and records, at the animal-data stage, both why exercise works and why it may work less completely as the underlying system degrades.

Metformin moved ageing markers, not metabolism - the prediabetes trial

16th October 2026

In a 24-week double-blind randomised trial, 127 Indian adults aged 30-60 with prediabetes received metformin 500 mg twice daily or placebo, both with lifestyle counselling; 112 finished. The metformin group showed larger rises in leukocyte telomere length, telomerase activity and SIRT1 expression than placebo - while weight, waist measures, glucose control and lipids did not differ significantly between groups.

Why it matters - This lands weeks after entry 25 recorded Peter Attia dropping metformin for longevity in healthy people. This trial is in prediabetes, not healthy ageing, and its own pattern - markers up, metabolism flat - is a clean example of why this library grades surrogate-marker results as emerging, not proven.

A blood score at menopause that tracks later brain health

16th October 2026

Researchers mapped blood proteins across the menopausal transition in healthy midlife women and found 16 proteins - spanning inflammation, synaptic, metabolic and Alzheimer-related processes - that shift with menopause stage rather than with age alone. Combined into a proteomic score, those shifts were associated in separate older cohorts with worse later cognition and higher Alzheimer dementia risk.

Why it matters - Entry 38 showed the postmenopausal ovary keeps remodelling; this entry shows the transition also leaves a readable signature in blood that connects to brain ageing. Together they make midlife in women one of the clearest intervention windows in this library.

Why raising NAD+ is not enough - the SIRT1 reserve problem

16th October 2026

A review in Biology argues that many NAD+ and SIRT1 therapies have disappointed because trials measure the wrong thing: how much NAD+ or SIRT1 is present, rather than whether SIRT1 can still respond under stress. The authors propose SIRT1 functional reserve - the remaining capacity of SIRT1-dependent processes to engage, coordinate and recover when a cell is challenged - as the metric that actually matters.

Why it matters - NAD+ boosters are already in this library's hype scorecard (entry 20). This entry records why the simple more-is-better logic behind them is now being questioned inside the field itself - and what a better test would have to show.

Life layering - build the layers before you need them

16th October 2026

Michael Clinton's "life layering" starts from the three Ps that define the first half of life - profession, partner, parenting - and argues for deliberately building further layers (interests, skills, communities) that you control, before work shifts or ends.

Why it matters - Most of this library measures the body; this entry is about the structure of a life. For readers planning 30-year second halves, identity diversification is as practical a preparation as a training plan.

Longevity Nation - the movement gets a field guide

16th October 2026

Michael Clinton - former president of Hearst Magazines, founder of ROAR Forward, and at 72 a marathon runner on seven continents - spent three years interviewing more than 70 longevity experts for Longevity Nation, his survey of the movement reshaping the second half of life.

Why it matters - This library tracks the longevity economy company by company; this is the movement's own map of itself, drawn by one of its central connectors - useful both as a directory of who matters and as a marker of how the field now presents itself.

The ovary after menopause - not retired, still remodelling

15th October 2026

Studying ovarian tissue from 28 women, Northwestern and Buck Institute researchers found the ovary stays biologically active decades after menopause - continuing to remodel, with rising inflammation and structural change - rather than sitting idle once fertility ends. The team also reports a molecular link between this ovarian aging process and cancer vulnerability.

Why it matters - Women spend decades of longer lives after menopause, yet the organ's post-reproductive biology has barely been mapped. If the ovary is an active aging organ, it belongs on the list of systems worth measuring - and women's healthspan research gains a concrete target.

A metabolic clock from 18,000 blood samples

15th October 2026

Researchers profiled plasma metabolites from 18,476 people aged 1 to 96 at six clinical centres in China, and built aging-clock models from the 56 metabolites that shift most reliably with age. Their headline metric, metabolomic age acceleration, tracked higher risk of fatty liver disease, hypertension, diabetes and death from any cause; a second metric rose with the severity of systemic disease.

Why it matters - Biological-age measurement is the scoreboard every longevity intervention will be judged by. A scalable blood-based clock is a candidate standard - and this entry records both its scale and its single-population limit at launch.

Dementia’s doubling - 24.7 million new cases a year by 2050

15th October 2026

Pooling individual data from 38,418 people in 22 population studies across 18 countries, researchers estimate 11.4 million people developed dementia in 2023 - a flow of new cases projected to reach 24.7 million a year by 2050 as populations age. Incidence runs higher in women than men even after age adjustment, and far higher in low- and middle-income countries than in rich ones.

Why it matters - A doubling inflow of dementia cases is a capacity problem - for care workforces, family caregivers, housing and health budgets - that lands well inside today's planning horizon. It is the demand side of the longevity economy that entries 14-16 describe from the opportunity side.

SRSF1 - one gene that made old cells read young

15th October 2026

A Harvard Wyss Institute team led by George Church built a machine-learning predictor of transcriptomic age - how old human skin cells read from their gene activity - and used it to screen candidate genes for ones that push old cells back toward a youthful reading.

Why it matters - Reprogramming is this library's highest-hype category (see entry 26). A single-gene route that preserves cell identity is a genuinely new direction - and this entry records it at the animal-data stage, so later claims can be judged against what was actually shown.

Protecting muscle on GLP-1s - IBIO-610 primate data

14th October 2026

iBio reported an eight-week study in obese nonhuman primates combining its investigational antibody IBIO-610 with semaglutide. In the combination group, lean mass made up about 6 percent of total weight lost, versus about 22 percent with semaglutide alone, and fat accounted for a larger share of the loss.

Why it matters - As GLP-1 use scales, the quality of weight loss - fat versus muscle - becomes a central healthspan question, especially for older users. This is an early candidate answer, tracked here at the animal-data stage so later human results can be judged against it.

Function meets Google Health - labs join the wearable stream

14th October 2026

Function Health and Google Health announced a partnership that will let US users share Function lab results into the Google Health app later this fall. The aim is to read daily wearable signals - sleep, resting heart rate, heart rate variability, cardio load - against periodic lab panels of more than 160 tests, with Function's Medical Intelligence layer translating results into guidance.

Why it matters - Preventive diagnostics is consolidating around whoever owns the daily health home screen. This deal is a marker for where the business of longevity data is heading - integration, not another standalone dashboard.

Eat to satiety, lose liver fat - the low-fat vegan diabetes trial

14th October 2026

Twenty-five adults with type 2 diabetes followed a low-fat vegan diet for 16 weeks, eating as much as they wanted with no calorie counting. They lost about 6 kg on average, liver fat fell by about a third, visceral fat shrank, and measures of insulin sensitivity and beta-cell function improved.

Why it matters - Type 2 diabetes is one of the clearest accelerators of unhealthy ageing. A dietary pattern that improves its core drivers without portion control is a practical, testable lever - and a useful counterpoint to drug-first framing.

Nature on prescription - the loneliness trial that lasted a year

14th October 2026

In a randomised controlled trial in Barcelona, 320 lonely older adults from 12 low-income neighbourhoods were assigned either to a small group doing nature-based activities together for two hours a week over nine weeks, or to the same activities on their own. Both routes reduced loneliness, and the benefit grew rather than faded over a year of follow-up.

Why it matters - Relationships are already this library's strongest longevity signal (entry 09); this is randomised-trial evidence that a low-cost, non-medical prescription - time in nature, with others - can move that signal, and that public health systems can deliver it.

Blue Zones Project comes to Tyler, Texas - designing a town for longer lives

13th October 2026

The Health Foundation of East Texas launched a Blue Zones Project in Tyler on 2026-10-12, applying Dan Buettner’s research on the world’s longest-lived communities to a whole city. Instead of prescribing individual habits, the project reshapes the Life Radius - the streets, parks, schools, workplaces, shops and homes where people spend most of their lives - so healthier choices become the easier choices.

Why it matters - It is the Blue Zones idea moving from description to implementation in a new American city - a live test of whether designed environments can reproduce what the original regions did by tradition.

ZNF865 - a little-known gene that guards the spine against senescence

13th October 2026

Researchers identified ZNF865 as a regulator of DNA damage and cell senescence in the nucleus pulposus cells that keep spinal discs healthy. Restoring its expression in degenerative human disc cells reduced DNA damage and senescence signals and increased collagen, while silencing its counterpart in rat disc cells produced degenerative changes and greater pain sensitivity in under two months.

Why it matters - Disc degeneration is one of the most common reasons long lives lose mobility and independence - a named, testable target moves it from wear-and-tear fatalism into geroscience.

Processing speed - the brain test that tracks survival

13th October 2026

In a cohort of 4,561 Australian adults followed for a median of 11.3 years, how quickly people processed information was independently linked to survival, alongside memory. Each standard-deviation increase in processing-speed performance was associated with a 32 percent lower risk of death, after adjustment for lifestyle, health and demographic factors.

Why it matters - It adds a simple cognitive measure to the numbers worth tracking over time - less about a single score, more about change in speed as an early signal to investigate.

Investing in longevity - planning to 95 is now prudent

12th October 2026

RBC Wealth Management frames longevity as a structural, not cyclical, investment theme: 2.1 billion people aged 60-plus by 2050, with the 80-plus group set to triple. The piece argues portfolios and retirement plans must adapt - at 3 percent inflation, 100 today buys roughly 41 of goods in 30 years - and that planning for a retirement lasting to 95 is now prudent rather than pessimistic.

Why it matters - It connects the library’s healthspan story to the money story - extra years only work if wealth planning assumes them, which is core territory for The business of it.

ER-100 - first human data for epigenetic reprogramming

12th October 2026

Life Biosciences reported interim Phase 1 data for ER-100, a one-time eye injection delivering the OSK reprogramming factors (Oct4, Sox2, Klf4), switched on by daily doxycycline, in three people with open-angle glaucoma. The low dose was tolerated over 56 days with no drug-related serious adverse events, and the safety board cleared escalation to a higher dose.

Why it matters - Partial reprogramming has moved from mouse work into a first human safety readout - a genuine milestone for the field, and a clear test case for separating a milestone from a proven therapy.

Strong convictions, loosely held - Attia revises his own playbook

12th October 2026

In AMA #90, Peter Attia looks back over 400 episodes and publicly updates positions he once held firmly: he no longer takes metformin for longevity, his confidence in rapamycin has cooled, and his views on extended fasting, keto, whole-body MRI and heavy barbell training have all become more conditional. The through-line is method, not dogma - durable principles and sustainable practice over marginal optimisation.

Why it matters - This is the evidence-over-hype lens applied by one of the field’s most cited voices to his own past advice - a useful model for how readers should hold every claim in this library.

Retail’s Vital Wellscapes - stores designed to make you well

12th October 2026

Retail is borrowing from health: salutogenic design, ecosomatic spaces that reconnect body and nature, and resilience-centring services.

Why it matters - The mood is documented - 70% of people feel the world is going in the wrong direction, but 69% refuse to let tough times keep them down (Havas, 2024).

The Future Members’ Club - wellness moves into the clubhouse

12th October 2026

Private members’ clubs are being rebuilt around passion and health: science-led longevity clubs with biohacking protocols, social wellness built on contrast bathing and intellectual stimulation, and curated travel communities - in a UHNW travel market heading to $142.7 billion by 2033.

The Experiential Elite - luxury trades objects for experiences

12th October 2026

Overexposed online and wary of material excess, luxury consumers now prize scarce experiences and knowledge as status: 32% of American luxury consumers want experiences they have never had before (Ogury, 2025), and brands answer with invite-only symposiums, co-creation with master makers, and learning as the new luxury good.

Tools for Better Living - the case for friction, friends, and getting outside

12th October 2026

Stylus maps four factors now essential to wellbeing: anti-ease (deliberately reintroducing friction, discomfort, and boredom), crucial connections, essential escape from screens into nature, and meaningful pleasures over mindless gratification.

Why it matters - A consumer-culture mirror of what the longevity evidence already says.

GLP-1s, rapamycin, NAD+ - the hype-vs-evidence scorecard

11th October 2026

Every longevity claim scored on the evidence, updated quarterly.

Why it matters - No claim without a rating.

Function Health - 100 biomarkers, annually

11th October 2026

The lab panel behind Equinox Optimize: about 100 biomarkers, drawn yearly and tracked over time.

Why it matters - Labs are the annual audit; rings are the daily ledger.

Prenuvo - the whole-body MRI goes mainstream

11th October 2026

Radiation-free full-body MRI in under an hour; roughly 150,000 scans done, 1 in 20 flagging a potentially life-saving finding.

Rethinking wealth planning for longevity

11th October 2026

Longer lives break retirement math.

Why it matters - For private wealth, longevity risk is now the central variable.

The future of healthy living - a $16.4 trillion opportunity

11th October 2026

The headline number for the global healthy-living market.

Why it matters - The commercial prize for evidence-backed longevity.

The Longevity Economy Outlook 2026

11th October 2026

The 50-plus contributed $1.2 trillion in unpaid care and volunteering in 2024.

Why it matters - By 2031, older Americans outnumber children.

Gray gold - the $5 trillion longevity economy

11th October 2026

Up to $5 trillion in untapped potential in employing older workers.

Why it matters - Older workers are an asset class, not a burden.

America’s growth strategy demands a health reset

11th October 2026

Scaling proven interventions could add 19 million years of healthy life by 2050 and $3.2 trillion to the US economy.

Stayin’ alive and well - the $2 trillion healthspan dividend

11th October 2026

Halving the burden of age-related disease could add $2 trillion to global GDP through workforce participation alone.

Evidence over hype - New York’s path to a healthy longevity economy

11th October 2026

Evidence-backed positioning lifts purchase intent 11 points among high spenders.

Why it matters - The anchor thesis of this library.

Purpose, stress, movement: what 21,000 older adults say matters

11th October 2026

Across 21 countries, adults 55+ rank purpose, stress management, activity and social interaction above medicine.

The Harvard Study of Adult Development

11th October 2026

80+ years of data: the clearest predictor of a long, healthy life is the quality of your relationships.

Why it matters - Loneliness harms like smoking.

The longevity retreat - the healthy vacation

11th October 2026

Chenot, SHA, Canyon Ranch, Sensei: the new luxury trip is a week of diagnostics, movement and sleep reset.

Why it matters - Recovery as destination.

The minestrone breakfast

11th October 2026

A savory minestrone - beans, greens, whole grains - as the day’s first meal, taken from Sardinia’s oldest family.

The Blue Zones - nine rules from the world’s longest-lived

11th October 2026

Five regions reach 100 at ten times the US rate.

Why it matters - Nobody there is on a program - longevity is the side effect of environment.

Why We Sleep

11th October 2026

Sleep is the single most effective reset for brain and body health.

Why it matters - Regularity beats duration.

The quantified self, without the noise

11th October 2026

Track what you will act on: sleep, resting heart rate, blood pressure, metabolic markers.

Why it matters - Most biohacking is theatre; some is signal.

Strength is the longevity drug

11th October 2026

Muscle mass and grip strength predict healthy aging better than almost any biomarker.

Why it matters - Two to three sessions a week is the dose.

Outlive - Medicine 3.0 and the Four Horsemen

11th October 2026

Medicine 3.0 is proactive: delay the onset of heart disease, cancer, neurodegeneration and metabolic disease by decades.

Why it matters - The cornerstone text.

Optimize by Equinox - the $40,000 longevity membership

11th October 2026

Three weekly training sessions, nutrition and sleep coaches, 100-biomarker blood panels and a concierge - the benchmark luxury longevity product, with a waitlist over 1,000.